Impact Factor
3.83
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.26
1,341 total citations
h5-index
34
h5 depth signal
Cited share
85.1%
274 of 322
Total citations
1,341
Citation footprint
Metric signal
3.57
External metric anchor
Self-citation
4.1%
55 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
653
China
332
Italy
222
Germany
124
United Kingdom
105
Citing Fields of Research
Dermatology
1,397
Allergies
533
Musculoskeletal Disorders
529
Auto-Inflammatory Disorders
142
Oncology
125
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,249
Articles tracked across the journal lifetime
Indexed publication set
322
274 cited publications
Last 12 months
200
16.7 publications/month
Open access share
100.0%
200 OA publications in the last year
Leading citing country
United States
653 citing publications
Leading citing field
Dermatology
1,397 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v12n1, Mar. 2001-
v12n1, Mar. 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Dermatology
Allergies
Musculoskeletal Disorders
Broad Categories
Dermatology
Musculoskeletal Disorders
Allergies
MeSH Descriptors
Skin Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/09546634.2026.2748762
Open DOI
Adalimumab durability in hidradenitis suppurativa: persistence is not synonymous with sustained response
02
03
DOI 10.1080/09546634.2026.2748079
Open DOI
A cross-sectional analysis of topical steroid phobia and observable side effects in Thai psoriasis patients
04
DOI 10.1080/09546634.2026.2742569
Open DOI
‘The good cancer’: communicating a hypopigmented mycosis fungoides diagnosis to families
05
06
DOI 10.1080/09546634.2026.2728531
Open DOI
Do genetic deficiency states predict the effect of pharmacologic target blockade?
07
08
DOI 10.1080/09546634.2026.2737487
Open DOI
Association of a Han Chinese urticaria-derived polygenic risk score with chronic spontaneous urticaria susceptibility and advanced systemic treatment use
Chronic urticaria (CU) lasts for more than six weeks and is characterized by recurrent wheals, angioedema, or both. CU is driven by activation of cutaneous mast cells and the release of histamine a...
09
DOI 10.1080/09546634.2026.2734960
Open DOI
Should we be monitoring patients on systemic dermatologic therapies for psychiatric adverse effects?: a proposed clinical framework
10
DOI 10.1080/09546634.2026.2727193
Open DOI
Mechanism-based reporting patterns of infection-related adverse events with systemic psoriasis therapies in FAERS
Bibliographical & Catalog Notes
Imprint varies.
Also issued online.
Vol. 5, no. 1 (JAN 1994)19960129 Notice published Printed on acid-free paper